Related Experiment Video
Updated: Jul 15, 2026
10:42
Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
Published on: April 11, 2019
Umbilical cord blood research: current and future perspectives
Jennifer D Newcomb1, Paul R Sanberg, Stephen K Klasko
1Center of Excellence for Aging and Brain Repair, Department of Neurosurgery, University of South Florida, College of Medicine, Tampa, FL 33612, USA.
Cell Transplantation
|May 4, 2007
Summary
Umbilical cord blood (UCB) banking offers biological insurance for future medical needs. Research is advancing UCB therapies, but challenges remain in cell expansion, safety, and proving efficacy for various diseases.
Area of Science:
- Regenerative Medicine
- Hematology
- Obstetrics
Background:
- Umbilical cord blood (UCB) banking is an emerging obstetrical trend.
- It provides a biological insurance policy for potential life-threatening illnesses.
- UCB offers patients more control over their treatment options.
Purpose of the Study:
- To highlight the potential of UCB banking and therapies.
- To identify current challenges and future directions in UCB research.
- To emphasize the rapid advancement of UCB-based treatments.
Main Methods:
- This abstract does not detail specific methods but discusses the research landscape.
- It focuses on the challenges and progress in UCB applications.
- Key areas include ex vivo cell expansion and clinical efficacy studies.
Main Results:
- UCB banking is gaining traction as a medical resource.
- Significant research is needed to establish UCB efficacy for diverse conditions.
- New UCB-based therapies are anticipated.
Conclusions:
- UCB banking holds promise but requires further research for widespread clinical adoption.
- Overcoming challenges in cell expansion, safety, and demonstrating broad utility is crucial.
- The field is progressing rapidly towards novel UCB applications.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...